Mechanisms Underlying Individual Variations of Taste and Smell in Obesity

ConditionObesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

About this trial

Background:

Changes to the sense of taste or smell can change eating behavior. This may contribute to obesity. Researchers want to see how taste and smell perceptions that affect food choices may differ between people with obesity and without obesity.

Objective:

To understand the role that senses of taste and smell play in food intake.

Eligibility:

Adults ages 18-65 with obesity and without obesity

Design:

Participants will be screened with a medical history and physical exam. They will have a neurological and sensory exam. They will give blood and urine samples. They will be checked for previous SARS-CoV-2 infection. They will complete questionnaires about their eating habits, alcohol use, and smoking history.

Participants will have 2 study visits.

Participants will give stool, urine, blood, hair, nasal, and saliva samples. These samples will be used for gene testing.

Participants will have their weight, height, and hip and waist circumference measured. They will have an imaging scan that measures body composition.

Participants will complete questionnaires about their health, eating habits, and food preferences.

Participants will have taste tests and smell tests. They will have sensory tests to assess their response to stimuli.

Participants will have a dietary assessment. They will complete a food diary and a diet history questionnaire.

Participants will get a meal to eat. Data will be collected about their experience.

Participants will complete a sleep diary and wear a watch to measure their activity....

Eligibility criteria

Qualifiers

Males and females between 18 to 65 years of age. Due to documented knowledge that taste and smell changes with age, we will limit the cohort within this age range.

BMI between 18.5 and 29.9 kg/m² for healthy controls or between 30 and 39.9 kg/m² for obese subjects

Fasted plasma glucose levels between 68-126 mg/dl or per Clinical Center ranges, and hemoglobin A1C<6.5%

Able to provide his/her own consent

Disqualifiers

Because type-2 diabetic subjects have blunted taste responses, subjects with diagnosis of type II diabetes will be excluded.

Hypoglycemic drug intake.

Weight change of more than 15 pounds in the 6 months prior to screening

Positive pregnancy test, currently pregnant or breastfeeding.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

350 Participants
are grouped into 2 trial groups